NewsRx Logo Login/Signup
Home Newsletters Products Library About Us Contact -- Search NewsRx

NewsRx | Free Trials
Advertisement
VerticalNews | Global Warming
Advertisement
NewsRx | Free Trials
Advertisement
----------
------------
NewsRx on Facebook
-----
Press Release Submissions
PR Login
*
*

Mental Health Weekly Digest

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Mental Health Weekly Digest

Learn More

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now



Parkinson Disease



Subthalamic nucleus deep brain stimulation cognitive sequelae are reviewed



August 28th, 2006

Subthalamic nucleus deep brain stimulation (STN DBS) cognitive sequelae in Parkinson's disease patients are reviewed.

According to a recent review from the United States, "STN DBS is an increasingly common treatment for Parkinson's disease. Qualitative reviews have concluded that diminished verbal fluency is common after STN DBS, but that changes in global cognitive abilities, attention, executive functions, and memory are only inconsistently observed and, when present, often nominal or transient."

T.D. Parsons and colleagues, University of North Carolina, wrote, "We did a quantitative meta-analysis to improve understanding of the variability and...


Source: Mental Health Weekly Digest (2006-08-28)

NewsRx Passes
Advertisement
More Articles

Related Topics

------------------------
Security by Verisign PR Login